Dr Michael Baker interviewed on the Marcus Today podcast
Dr Michael Baker, CEO and MD, shared Arovella’s story with Henry Jennings on the Marcus Today podcast. Dr Baker discussed Arovella’s iNKT cell therapy, an “off-the-shelf” approach that tackles blood cancers with better cost efficiency.
